Mitochondrial function as a therapeutic target in heart failureDavid A. Brown, Mihai Gheorghiade, Justin B. Perry et al.|Nature Reviews Cardiology|2016Cited by 786
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection FractionRobert J. Mentz, Christopher M. O’Connor, Jacob P. Kelly et al.|Journal of the American College of Cardiology|2014Cited by 541
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAndrew A. House, Stefan Störk, John G.F. Cleland et al.|Kidney International|2019Cited by 435
Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart FailureAlessandra Dei, Gregg C. Fonarow, Sadiya S. Khan et al.|JACC Heart Failure|2015Cited by 409
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection FractionMihai Gheorghiade, Stephen J. Greene, Javed Butler et al.|JAMA|2015Cited by 389